Navigation Links
Global Immunology Market to 2022 - Large pipeline and competitive market to drive long-term market growth
Date:2/4/2016

LONDON, Feb. 4, 2016 /PRNewswire/ -- Global Immunology Market to 2022 - Large pipeline and competitive market to drive long-term market growth

Summary

Immune-mediated inflammatory diseases are a very common set of chronic disorders that affect 5–7% of western populations. Although they are often disparate in terms of their symptoms and key patient demographics, they are pathophysiologically linked, being characterized by dysregulation of immune pathways and an inappropriate immune response. Generally, disease-modifying anti-rheumatic drugs, a highly genericized class of systemic small-molecule-based agents, are used in the first-line treatment of these diseases. These are supplemented in many cases by shorter-term glucocorticoid therapy, another class of highly genericized systemic agents.

However, as these therapies often fail to elicit an adequate long-term response, a large second-line therapy segment has emerged in these markets, beginning with the approval of Remicade (infliximab) and Enbrel (etanercept) in 1998. This segment consists largely of premium systemic monoclonal Antibodies (mAbs), which are highly commercially successful due to their widespread usage and high cost. Although the patents for many of these mAbs either have already expired or are due to expire during the forecast period, the market is expected to experience continued growth.

Scope

Although the patents for many of these mAbs either have already expired or are due to expire during the forecast period, the market is expected to experience continued growth, from $61.5 billion in 2015 to $74.2 billion in 2022, at a compound annual growth rate of 2.71%.
- What factors are driving the market growth?
- How can the factors limiting growth be overcome?
There is a very large pharmaceutical pipeline for immunology, consisting of 1,838 products in active development. However, the commercial performance of the products in the late-stage pipeline is expected to be moderate.
- What gaps in the market are being addressed by the most promising of these late-stage pipeline products?
- How does the composition of the pipeline compare with that of the existing market?
Several key commercially successful products, including Humira (adalimumab) and Remicade, are due to lose patent protection in the forecast period.
- How will this affect their revenues in this period?
- How are their manufacturers, AbbVie and Johnson & Johnson, responding to this?
The key players in the market, all of which are among the top 20 pharmaceutical companies, are expected to maintain their market lead throughout the forecast period.
- What is driving this continued market dominance?
- Who will the new market players be?

Reasons to buy

This report will allow you to -
- Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis and the treatment options available at each stage of diagnosis
- Visualize the composition of the immunology market across each indication, in terms of dominant molecule types and targets, highlighting the key commercial assets and players
- Analyze the immunology pipeline and stratify by stage of development, molecule type and molecular target, with a granular breakdown across key indications
- Understand the growth in patient epidemiology and market revenues for the immunology market globally and across the key players and product types
- Stratify the market in terms of the split between generic and premium products and assess the role of these product types in the treatment of the various immunological disorders
- Identify commercial opportunities in the immunology deals landscape by analyzing trends in licensing and co-development deals
Download the full report: https://www.reportbuyer.com/product/3596608/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com


'/>"/>
SOURCE ReportBuyer
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Viral Partnering Deal Trends, Players and Financials Analysis Report 2016
2. Global Breast Pumps Market Assessment & Forecast: 2015 - 2019
3. Global Life Science Microscopy Devices Market Assessment & Forecast: 2015 - 2019
4. Haemophilus influenzae Infections Global Clinical Trials Review, H2, 2015
5. Atomic Spectroscopy Market by Technology & by Application - Analysis & Global Forecast to 2020
6. Neurocrine Biosciences to Present at the Leerink Partners 5th Annual Global Healthcare Conference
7. Global Blood Glucose Testing and Diabetes Management Report 2015
8. HeartWare Presentation At The Leerink Partners 5th Annual Global Healthcare Conference To Be Webcast
9. ARMO BioSciences to Present at the Leerink Partners Global Healthcare Conference
10. Medical Ceramics Market by Material, by Application, and by Region - Global Forecast to 2020
11. Luminex Corporation To Present At 2016 Leerink Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2020)... (PRWEB) , ... September 02, 2020 , ... ... 1064nm Raman technology, will moderate a roundtable discussion among industry professionals about successes ... will be hosted by American Pharmaceutical Review and will take place ...
(Date:9/1/2020)... N.Y. (PRWEB) , ... September 01, 2020 , ... ... dermatologist, and Director of Cosmetics and Laser Surgery at the University of Rochester ... Dermatologic Surgery fellowship at SkinCare Physicians in Boston, with clinical faculty from the ...
(Date:9/1/2020)... ... 2020 , ... September is National Ovarian Cancer Awareness Month. Ovarian cancer ... cancer of the female reproductive system. The American Cancer Society estimates that in ... will die from this disease. Throughout the month of September, Women’s Excellence aims ...
Breaking Medicine Technology:
(Date:8/29/2020)... ... August 29, 2020 , ... When professor and author Randy Pausch was diagnosed ... people would. Rather than become melancholic, however, he put together a final lecture in ... Randy Pausch took a negative situation and turned it into something that inspired millions ...
(Date:8/28/2020)... (PRWEB) , ... August 28, 2020 , ... ... assist system designed to help treat patients with respiratory conditions, including COVID-19, while ... of helium and oxygen, but it captures exhaled gas and scrubs it free ...
(Date:8/28/2020)... ... August 28, 2020 , ... ... Group set out to continue helping the specialty-diet community connect with great, ... gluten-free products, get coupons, enter giveaways, chat with brands & watch over 50 ...
(Date:8/28/2020)... , ... August 28, 2020 , ... ... in advising Adventist Health on its investment in Synchronous Health, a tech-enabled behavioral ... that combines the strength of human empathy with artificial intelligence (AI) to increase ...
(Date:8/27/2020)... ... August 27, 2020 , ... Walk-in Dermatology’s SK-IN ... in its Greenvale, New York location. , Loren received her New York ... is certified in chemical peels, microdermabrasion, Hydrafacial MD, dermaplaning, facial lymphatic, and various ...
Breaking Medicine News(10 mins):